Philips' automated early detection and warning solution to detect patient deterioration (IntelliVue GuardianSoftware) simplifies workflow and automates some steps in patient rounding and assessments as well as frequently trending vitals and other key information to identify at-risk patients. It allows for critical notifications to be directly delivered to the care team's (mobile) devices, even when on the go. The interoperable solution natively integrates with Children's Philips patient monitoring systems, sends validated patient data directly to the EMR and the admission, discharge, and transfer (ADT) system. By automating this process and eliminating labor-intensive manual tasks, Children's PEWS can be used with minimized opportunities for error and increased opportunities for early intervention, while also giving health care professionals more time to spend with patients.
"Not only has Augusta University Health pioneered long-term strategic partnerships here in the U.S., they have worked closely with us to push the boundaries of health care – from same-day diagnosing and treatment of lung cancer in the hybrid operating room, to improving workflows as part of Children's new design," said Vitor Rocha, Chief Philips North America, member of the Executive Committee Royal Philips. "The implementation of Philips' automated early detection and warning solution at Children's is another example of their commitment to providing breakthrough, family-centered care, while ensuring the best possible working environment for their staff."
Ad Statistics
Times Displayed: 79227
Times Visited: 2801 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
Philips has a broad portfolio of patient monitoring, telehealth, predictive analytics solutions and services for care providers and patients at home.
Unit: 4CMC – Pediatrics Medicine Measurement period: 7 months. This data is exclusive to Children's Hospital of Georgia.
Results from case studies are not predictive of results in other cases. Results in other cases may vary.
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 80,000 employees with sales and services in more than 100 countries.
